Cyclerion Therapeutics, Inc. - Common Stock – Quartalsfinanzdaten (NASDAQ:CYCN) | MetaTrader

Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Mittelzufluss aus laufender Geschäftstätigkeit 360 K-968 K-503 K-264 K-1.58 M-1.18 M -3.52 M Mittelzufluss aus Investitionstätigkeit 0————-66 K — Zahlungsströme aus der Finanzierungstätigkeit 01.38 M-130 K1.83 M251 K825 K 2.77 M Freier Cashflow 360 K-968 K-503 K-264 K-1.58 M-1.24 M -3.59 M

Nachrichten

Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.48%

Cyclerion Therapeutics, Inc. (CYCN) M&A Call Prepared Remarks Transcript

Cyclerion erhält positives FDA-Feedback für Entwicklung von Depressionstherapie

Cyclerion receives FDA feedback on depression treatment development

Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Acrivon Therapeutics (NASDAQ:ACRV), AZZ (NYSE:AZZ)

Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression - Slideshow (NASDAQ:CYCN) 2026-01-07

Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression Prepared Remarks Transcript

Dow Jumps Over 400 Points; US Services Activity Falls In December - Aeva Technologies (NASDAQ:AEVA), Alumis (NASDAQ:ALMS)

US Stocks Mixed; Nasdaq Gains Over 50 Points - Alumis (NASDAQ:ALMS), AngioDynamics (NASDAQ:ANGO)

Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Aeva Technologies (NASDAQ:AEVA), Alumis (NASDAQ:ALMS)

Cyclerion-Aktie mit massivem Kurssprung nach strategischer Kooperation mit Medsteer